• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Social Media Guidance

Public Health Outcome: Improve FDA’s social media program by standing up an agency wide social media work group to develop social media policies and standardize best practices. This policy will govern how FDA manages its social media programs and as new channels are developed.

Briefing Status: Delayed

Prior Briefing Status: Delayed

Milestone DescriptionMilestone DateMilestone StatusMilestone Completion Date

A. Create an FDA-wide social media working group to discuss social media policy, strategy, and best practices. Group will also discuss current developments in social media as well as social media collaboration within FDA.


Completed 4/18/2013

B. Develop FDA-wide social media policy that establishes the principles and provides guidance for the use of social media at FDA


Completed 12/1/2013

C. OCC to complete initial review of the new social media policy


Completed 3/18/2015

D. OEA to address and incorporate OCC's feedback


On Track TBD

E. OCC to complete last/final review of policy


On Track TBD

F. Implement FDA-wide social media policy



Delayed TBD

Key Projects Legend

Milestone StatusDefinition
Not Yet StartedWork for specific milestone has not yet been started.
CompletedMilestone and/or overall project is completed.
On TrackMilestone - On track for completion by milestone deadline. Quarter status - Project is on track for completion based on overall milestone status.
On HoldMilestone - On hold, but deadline for completion has not passed. Quarter status - Project is on hold, based on overall milestone status.
DelayedMilestone - Delayed as it has not been completed and deadline has passed. Quarter status - Project is delayed based on overall milestone status.


Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.